May 30, 2024--Researched by Industrial Info Resources (Sugar Land, Texas)--Global pharmaceutical firm Eli Lilly and Company (NYSE:LLY) (Indianapolis, Indiana) last week announced that it would increase its investment in a facility in Lebanon, Indiana, by a further $5.3 billion. The facility will manufacture the active pharmaceutical ingredient (API) used in drugs for obesity and diabetes.